14.12.2009
- Glaxosmithkline is extending its product portfolio in the Middle East. The company has acquired the branded generics business of Bristol-Myers Squibb in Lebanon, Jordan, Syria...
14.12.2009
- Johnson & Johnson said it completed its initial tender offer for Cougar Biotechnology and will commence subsequent offering period. According to J&J approximately 84.4 % of...
14.12.2009
- H. Lundbeck has agreed to buy privately owned Danish biotechnology firm Neuronicon to gain technologies for treating brain damage. Lundbeck, whose main products are anti...
14.12.2009
- Air Liquide has just completed the acquisition of Al Khafrah Industrial Gases, a company headquartered in Riyadh with more than $20 million of sales in 2008. Sheikh Mubarak Al...
14.12.2009
- French drugmaker Sanofi-Aventis will close eight of its 27 research and development sites, without making forced layoffs, as it remodels R&D activities to respond to changes in the...
14.12.2009
- Glaxosmithkline announced collaboration with Chroma Therapeutics to developmacrophage-targeted compounds. Chroma has the potential to receive in excess of $1 billion in total...
14.12.2009
- Germany's Boehringer Ingelheim has signed a deal worth up to $242 million with U.S. biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the...
14.12.2009
- Dow Chemical and Russia's Gazprom Marketing and Trading said they will work together to develop and implement greenhouse gas reduction projects around the world. The companies...
14.12.2009
- Dupont and Bayer Cropscience announced the expansion of their collaboration with broad license agreements. Dupont said the agreements are partly related to key plant biotechnology...
14.12.2009
- Pros & Cons - Complying with current regulations within the pharmaceutical industry is an increasingly complex and rigorous process as regulatory bodies continue to step up the...
